Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Osiris Therapeutics, Inc. (OSIR)

« Back to company index

OSIR Chatter Timeline

Stock Ticker for OSIR

Most Active Tweeters for OSIR

UserTweets
@bulletin_en 3

Recent Tweets for OSIR

bulletin_en @bulletin_en
Achillion Pharmaceuticals Inc. $OSIR Comparing side by side https://t.co/yUBdBNDxHz
May 23rd 2019, 6:05pm
bulletin_en @bulletin_en
Comparing of BiondVax Pharmaceuticals Ltd. $OSIR https://t.co/YpTwX7q9TT
May 19th 2019, 5:05am
bulletin_en @bulletin_en
Neon Therapeutics Inc. $OSIR https://t.co/FwrMpTKIpW
May 16th 2019, 12:05am
NewsToDesk @NewsToDesk
$OSIR: Is Osiris Therapeutics, Inc. (OSIR) A Good Stock To Buy?: https://t.co/6k15Y5kqgU
May 9th 2019, 8:05pm
FinZTribune @FinZTribune
Contrasting of Arvinas Holding Company LLC $OSIR https://t.co/HNh8UOOuWG
May 6th 2019, 11:05pm
FinZTribune @FinZTribune
Contrasting of Mersana Therapeutics Inc. $OSIR https://t.co/RNTD6u6xmC
May 4th 2019, 11:05pm
FinZTribune @FinZTribune
Comparison of OncoSec Medical Incorporated $OSIR https://t.co/vySKAQl6Or
May 2nd 2019, 2:05pm
Allstocknews @Allstocknews
$OSIR New Form 15-12B for Osiris Therapeutics, Inc. From our Stock News Alerts App
April 29th 2019, 4:04pm
Stock_News_Now @Stock_News_Now
$OSIR: New SEC Filing for OSIR: Form 15-12B (No. 0001104659-19-024528): https://t.co/xRkEmbY0Go
April 29th 2019, 4:04pm
lukerehmann @lukerehmann
Osiris Therapeutics $OSIR were delisted pending a cash merger. #stock #stocks
April 22nd 2019, 6:04pm
thefinreviewer @thefinreviewer
Intrexon Corporation $OSIR Comparing side by side https://t.co/L7LMOApGNo
April 18th 2019, 7:04pm
bulletin_en @bulletin_en
Caprock Group Boosted Stake in Osiris Therapeutics New $OSIR as Valuation Rose; Qv Investors Has Trimmed Stake in A… https://t.co/UMHg6BPGtw
April 18th 2019, 10:04am
mergerpie @mergerpie
RT @DPD_Mergers: Smith & Nephew plc has completed its $650 mil acquisition of Osiris Therapeutics $OSIR
April 17th 2019, 11:04am
DPD_Mergers @DPD_Mergers
Smith & Nephew plc has completed its $650 mil acquisition of Osiris Therapeutics $OSIR
April 17th 2019, 11:04am
InsiderAlertsIA @InsiderAlertsIA
$OSIR: New Insider Filing on Director PETER FRIEDLI: https://t.co/V8StTwW2Eu
April 17th 2019, 11:04am
Allstocknews @Allstocknews
$OSIR New Form 25-NSE for Osiris Therapeutics, Inc. From our Stock News Alerts App
April 17th 2019, 9:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of https://t.co/kaoPCMbb1l
April 17th 2019, 9:04am
confcalltran @confcalltran
Notification filed by national security exchange to report the removal from listing and registr https://t.co/QyRJ0kIeXJ $OSIR
April 17th 2019, 9:04am
StockTexts @StockTexts
$OSIR Osiris Therapeutics, Inc. SEC Filing: Form 4 https://t.co/OvjoAhytxf
April 17th 2019, 9:04am
Allstocknews @Allstocknews
$OSIR New Form 4 for Osiris Therapeutics, Inc. From our Stock News Alerts App
April 17th 2019, 9:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Statement of Changes in Beneficial Ownership (4) https://t.co/D7om3AXHv8
April 17th 2019, 9:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Statement of Changes in Beneficial Ownership (4) https://t.co/Y65TLRGBN4
April 17th 2019, 9:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Statement of Changes in Beneficial Ownership (4) https://t.co/1kOWdf4jbf
April 17th 2019, 9:04am
StockTexts @StockTexts
$OSIR Osiris Therapeutics, Inc. SEC Filing: Form S-8 POS https://t.co/vTsQjTyasT
April 17th 2019, 9:04am
Allstocknews @Allstocknews
$OSIR New Form S-8 POS for Osiris Therapeutics, Inc. From our Stock News Alerts App
April 17th 2019, 9:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Post-effective Amendment to an S-8 Filing (s-8 Pos) https://t.co/8wImp97Ctj
April 17th 2019, 9:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Post-effective Amendment to an S-8 Filing (s-8 Pos) https://t.co/aTEjYp6KKN
April 17th 2019, 9:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Post-effective Amendment to an S-8 Filing (s-8 Pos) https://t.co/4E6E9bAmsV
April 17th 2019, 9:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Post-effective Amendment to an S-8 Filing (s-8 Pos) https://t.co/ZL8OIzSXZy
April 17th 2019, 9:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Post-effective Amendment to an S-8 Filing (s-8 Pos) https://t.co/GXgDPf6Vpw
April 17th 2019, 9:04am
confcalltran @confcalltran
Osiris Therapeutics, Inc. Announces Closing Of Acquisition By Smith %26 Nephew Plc https://t.co/GcOOe4YhPE $OSIR
April 17th 2019, 9:04am
StockTexts @StockTexts
$OSIR Osiris Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/QhveRxKYSn
April 17th 2019, 9:04am
Allstocknews @Allstocknews
$OSIR Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc From our Stock News Alerts App
April 17th 2019, 9:04am
StockHaltBot @StockHaltBot
HALTED: $OSIR Date: 2019-04-17 Time: 9:09:54 Code: T12 #LowFloat
April 17th 2019, 9:04am
StockTexts @StockTexts
$OSIR Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc Nasdaq:OSIR https://t.co/Ovu7T5i0nE
April 17th 2019, 9:04am
LargeVoidBot @LargeVoidBot
$OSIR Halt - Additional Information Requested by NASDAQ. Halt time: 09:09:54.
April 17th 2019, 9:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc https://t.co/N6mrq6asyO
April 17th 2019, 9:04am
mergerpie @mergerpie
RT @MergeArbLimited: $OSIR Osiris Therapeutics (Acq: Smith & Nephew $SNN) TENDER OFFER COMPLETION. 61% Tendered. Expected close 30-Jun-19…
April 17th 2019, 8:04am
MergeArbLimited @MergeArbLimited
$OSIR Osiris Therapeutics (Acq: Smith & Nephew $SNN) TENDER OFFER COMPLETION. 61% Tendered. Expected close 30-Jun-… https://t.co/DUr4KytOsZ
April 17th 2019, 7:04am
StockTexts @StockTexts
$SNN $OSIR Osiris Therapeutics, Inc. SEC Filing: Form SC TO-T/A https://t.co/pZpzN8Ndec
April 17th 2019, 6:04am
StockTexts @StockTexts
$OSIR Osiris Therapeutics, Inc. SEC Filing: Form SC 14D9/A https://t.co/pj4pytkSpf
April 17th 2019, 6:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Amended Tender Offer Statement by Third Party (sc To-t/a) https://t.co/eCi8MsDyQx
April 17th 2019, 6:04am
VisualStockRSRC @VisualStockRSRC
$OSIR - Amended Statement of Ownership: Solicitation (sc 14d9/a) https://t.co/0RTS8fSbBl
April 17th 2019, 6:04am
confcalltran @confcalltran
Tender offer statement by Third Party https://t.co/l4yWWGEmzv $OSIR
April 17th 2019, 6:04am
whatsonthorold2 @whatsonthorold2
Is Buying Osiris Therapeutics Inc $OSIR, Having Lower Short Interest a Winning Strategy? https://t.co/BJflPFi6hZ
April 16th 2019, 3:04pm
bibeypost_stock @bibeypost_stock
Osiris Therapeutics Inc $OSIR Reports Decline in Sellers; Strong Momentum for Longs https://t.co/Qy65ZdFlRG
April 16th 2019, 3:04pm
biotechfan20 @biotechfan20
$OSIR Board, consider obtaining more reasonable price for existing products (grafix, bio4, cartiform) that more app… https://t.co/IxLytEYAbA
April 16th 2019, 11:04am
biotechfan20 @biotechfan20
With this new event the probability of milestone and royalty income from MESO to $OSIR is significantly enhanced; a… https://t.co/Zydc4q1FqC
April 16th 2019, 10:04am
Stock_News_Now @Stock_News_Now
$OSIR: New SEC Filing for OSIR: Form SC 14D9/A (No. 0001104659-19-021494): https://t.co/egRqQJ7PYc
April 16th 2019, 9:04am
StockTexts @StockTexts
$OSIR Osiris Therapeutics, Inc. SEC Filing: Form SC 14D9/A https://t.co/3DjuFp8q9d
April 16th 2019, 9:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.